(Q43795420)

26 November 2017

title

Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma (English)

1 reference

26 November 2017

0 references

1 reference

1

1 reference

26 November 2017

Rocchina Caivano

2

1 reference

26 November 2017

Costanza Chiumento

3

1 reference

26 November 2017

Mariella Cozzolino

4

1 reference

26 November 2017

Stefania Clemente

5

1 reference

26 November 2017

Piernicola Pedicini

6

1 reference

26 November 2017

Vincenzo Fusco

7

1 reference

26 November 2017

publication date

12 May 2012

1 reference

26 November 2017

1 reference

26 November 2017

volume

29

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

3467-3471

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Treatment of glioblastoma in "elderly" patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Overtreatment of men with low-risk prostate cancer and significant comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Prognostic importance of comorbidity in a hospital-based cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Radiation therapy in the elderly: more side effects and complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Cancer and comorbidity in older patients: a descriptive profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Low-dose rate brachytherapy of the prostate in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0246-4

Safety and efficacy of radiotherapy treatment in elderly patients with localized prostate cancer: a retrospective analysis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Science of cancer and aging

1 reference

12 December 2020

The impact of comorbidity on treatment-related side effects in older patients with laryngeal cancer

1 reference

12 December 2020

Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer

1 reference

12 December 2020

Epidemiology of brain tumors

1 reference

12 December 2020

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials

1 reference

12 December 2020

Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia

1 reference

12 December 2020

10.1007/S12032-012-0246-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1018065720

0 references

1 reference